Friday, March 4, 2011

Dr Reddy -. Expect a Solid Quarter Ahead - ALLEGRA D-24 US LAUNCH VERY STRONG

In just one month post US launch - Allegra D-24 has taken 60% of the market share. The annual branded sales of Allegra D-24 in the US in  $180m. With a 60% market share and 30% price erosion, Dr. Reddy should be able to generate $60m in annual sales this year, and the bottom line impact should be $40m ( INR 180 Crores to the bottom line).  It should add Rs 10/share on the annual EPS.